Diabetes Research and Clinical Practice
Volume 34, Issue 1 , Pages 13-22 , September 1996

Effect of a novel hypoglycemic agent, KAD-1229 on glucose metabolism and fructose-2,6-bisphosphate content in isolated hepatocytes of normal rats

Received 20 December 1995 ,Revised 16 August 1996 ,Accepted 18 August 1996.

References 

  1. Rajan AS, Aguilar BL, Nelson DA, et al.  Ion channels and insulin secretion. Diabetes Care. 1990;13:340–363
  2. Barnes AJ, Crowley M, Garbien K, Bloom A. Effect of short and long term chlorpropamide treatment on insulin release and blood glucose. Lancet. 1974;2:69–72
  3. Feldman JM, Levobitz HE. Endocrine and metabolic effects of glibenclamide: evidence for an extra-pancreatic mechanism of action. Diabetes. 1971;20:745–755
  4. DeFronzo RA, Simonson DC. Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals. Diabetes Care. 1984;1:72–80
  5. Kolterman OG, Gray RS, Shapiro G, Scarlett JA, Griffin J, Olefsky JM. The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects. Diabetes. 1984;33:346–354
  6. Zawadski J, Wolfe R, Mott D, Lillioja B, Howard B, Bogardus C. Increased rate of Cori cycle in obese subjects with NIDDM and effects of weight reduction. Diabetes. 1988;37:154–159
  7. Consoli A, Nurjhan N, Reilly JJ, Bier DM, Gerich JE. Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism. J. Clin. Invest. 1990;86:2038–2045
  8. McGuinness OP, Green DR, Cherrington AD. Glyburide sensitizes perfused rat liver to insulin-induced suppression of glucose output. Diabetes. 1987;36:472–476
  9. Fleig WE, Noether FG, Fussgaenger R, Ditschuneit H. Modulation by a sulfonylurea of insulin-dependent glycogenesis, but not of insulin binding, in cultured rat hepatocytes. Evidence for a postreceptor mechanism of action. Diabetes. 1984;33:285–290
  10. Pilkis SJ, El-Maghrabi MR, Claus TH. Fructose-2,6-bisphosphate in control of hepatic gluconeogenesis. From metabolites to molecular genetics. Diabetes Care. 1990;13:582–599
  11. Van Schaftingen E. Glycolysis revisited. Diabetologia. 1993;36:581–588
  12. Monge L, Mojena M, Ortega JL, Samper B, Cabello MA, Felíu JE. Chlorpropamide raises fructose-2,6-bisphosphate concentration and inhibits gluconeogenesis in isolated rat hepatocytes. Diabetes. 1986;35:89–96
  13. Matsutani A, Kaku K, Kaneko T. Tolbutamide stimulates fructose-2, 6-bisphosphate formation in perfused rat liver. Diabetes. 1984;33:495–498
  14. Ohnota H, Koizumi T, Tsutsumi N, Kobayashi M, Inoue S, Sato F. Novel rapid- and short-acting hypoglycemic agent, a calcium(2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide. J. Pharmacol. Exp. Ther. 1994;269:489–495
  15. Ohnota H, Koizumi T, Kobayashi M, Momose Y, Sato F. Normalization of impaired glucose tolerance by the short-acting hypoglycemic agent calcium (2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) in non-insulin-dependent diabetes mellitus rats. Can. J. Physiol. Pharmacol. 1995;73:1–6
  16. Berry MN, Friend DS. High-yield preparation of isolated rat liver parenchymal cells. J. Cell. Biol. 1969;43:506–520
  17. Hotta N, Komori T, Kobayashi M, Sakakibara F, Koh N, Sakamoto N. The inhibitory action of buformin, a biguanide on gluconeogenesis from alanine and its transport system in rat livers. Diabetes Res. Clin. Pract. 1993;19:49–58
  18. Felíu JE, Mojena M, Correas I, Marco J. Lack of effect of bovine pancreatic polypeptide on glucose production by isolated rat hepatocytes. Diabete. Metab. 1982;2:141–145
  19. Claus TH, Plikis SJ, Park CR. Stimulation by glucagon of the incorporation of U-14C-labeled substrates into glucose by isolated rat hepatocytes. Biochim. Biophys. Acta. 1975;404:110–123
  20. Felíu JE, Hue L, Hers HC. Hormonal control of pyruvate kinase activity and of gluconeogenesis in isolated rat hepatocytes. In: 2nd edn. Proc. Natl. Acad. Sci. USA. 73:1976;p. 829–837
  21. Hohorst HJ. l-(+)-Lactate determination with lactic dehydrogenase and DPN. In:  Bergmeyer H editors. Methods of Enzymatic Analysis. New York: Academic Press; 1965;p. 266–270
  22. Hohorst HJ. d-glucose 6-phosphate and d-fructose 6-phosphate. Determination with glucose 6-phosphate dehydrogenase and phosphoglucose isomerase. In:  Bergmeyer H editors. Methods of Enzymatic Analysis. Orlando, FL: Academic Press; 1965;p. 134–138
  23. Van Schaftingen E, Lederer B, Bartrons R, Hers HG. A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate. Eur. J. Biochem. 1982;129:191–195
  24. Gliemann J. Insulin-like activity of dilute human serum assayed by an isolated adipose cell method. Diabetes. 1965;14:643–649
  25. Bartrons R, Hue L, Van Schaftingen E, Hers HG. Hormonal control of fructose-2,6-bisphosphate concentration in isolated rat hepatocytes. Biochem. J. 1983;214:829–837
  26. Van Schaftingen E, Davies DR, Hers HG. Fructose-2,6-bisphosphatase from rat liver. Eur. J. Biochem. 1982;124:143–149
  27. López-Alarcón L, Muñoz-Alonso MJ, Guijarro C, Felíu JE. Modulation of glycogen phosphorylase activity and fructose 2,6-bisphosphate levels by glibenclamide and meglitinide in isolated rat hepatocytes: a comparative study. Metabolism. 1995;44:1000–1007
  28. Monge L, Cabello MA, Samper B, Mojena M, Felíu JE. Tolbutamide enhances insulin action on gluconeogenesis and on fructose 2,6-bisphosphate levels in isolated rat hepatocytes. Diabete. Metab. 1988;14:712–716
  29. Cabello MA, Monge L, Ortega JL, Samper B, Felíu JE. Effect of glipizide on hepatic fructose 2,6-bisphosphate concentration and glucose metabolism. Metabolism. 1987;36:738–742
  30. Cabello MA, Rodriguez TG, Ortega JL, Samper B, Felíu JE. Inhibition of gluconeogenesis by tolbutamide in isolated rat hepatocytes: modulation of glucose-6-phosphate substrate cycle. Metabolism. 1991;40:934–940
  31. Hers HG, Van SE. Fructose 2,6-bisphosphate 2 years after its discovery. Biochem. J. 1982;206:1–12
  32. Hers HG, Hue L. Gluconeogenesis and related aspects of glycolysis. Annu. Rev. Biochem. 1983;52:617–653
  33. Neely P, El MM, Pilkis SJ, Claus TH. Effect of diabetes, insulin, starvation, and refeeding on the level of rat hepatic fructose 2,6-bisphosphate. Diabetes. 1981;30:1062–1064
  34. El MM, Claus TH, Pilkis J, Pilkis SJ. Regulation of 6-phosphofructo-2-kinase activity by cyclic AMP-dependent phosphorylation. In: 2nd edn. Proc. Natl. Acad. Sci. USA. 79:1982;p. 315–319
  35. Sakakibara R, Kitajima S, Uyeda K. Differences in kinetic properties of phospho and dephospho forms of fructose-6-phosphate, 2-kinase and fructose 2,6-bisphosphatase. J. Biol. Chem. 1983;259:41–46
  36. Ayame H, Matsutani A, Inoue H, Kaneko T, Kaku K. Tolbutamide inhibits glucagon-induced phosphorylation of 6PF-2-K/Fru-2,6-P2ase in rat hepatocytes. Am. J. Physiol. 1995;268:E391–E396
  37. López-Alarcón L, Berbil-Bautista PR, Guijarro C, Felíu JE. Glipentide and glucose metabolism in isolated rat hepatocytes. Biochem. Pharmcol. 1988;37:3177–3182
  38. Uyeda K, Furuya E, Richards CS, Yokoyama M. Fructose-2,6-P2, chemistry and biological function. Mol. Cell. Biochem. 1982;48:97–120
  39. Pilkis SJ, El MM, McGrane M, Pilkis J, Fox E, Claus TH. Fructose 2,6-bisphosphate: a mediator of hormone action at the fructose 6-phosphate/fructose 1,6-bisphosphate substrate cycle. Mol. Cell. Endocrinol. 1982;25:245–266
  40. Hue L, Blackmore PF, Exton JH. Fructose 2,6-bisphosphate. Hormonal regulation and mechanism of its formation in liver. J. Biol. Chem. 1981;256:8900–8903
  41. Mannaerts G, Debeer L, DeSchepper PJ. Metabolic effects of hypoglycemic sulfonylureas-III, Effect of chlorpropamide on energy metabolism and ketogenesis in the isolated perfused rat liver. Biochem. Pharmacol. 1974;23:75–87
  42. Patel TB. Effects of tolbutamide on gluconeogenesis and glycolysis in isolated perfused rat liver. Am. J. Physiol. 1986;250:E82–E86

PII: S0168-8227(96)01331-9

Diabetes Research and Clinical Practice
Volume 34, Issue 1 , Pages 13-22 , September 1996

Article Tools